VIVXF - Avivagen Inc. (VIVXF) - Getting New Sales

New Orders. Avivagen's management reported last Friday that the Company has received three new orders of the Company’s companion animal products, one from Taiwan and two from Mexico. The order from Taiwan is for 1,500 units, while Mexico has orders of 4,000 units and 500 units. The Company is seeing great interest in the companion animal market today. These new sales and customer wins in key markets like Taiwan and Mexico follow sales in Canada and the U.S., and are clear signs of the growing demand for the Company's companion animal product as an important part of promoting pet health. The companion animal products are one branch of the the Company's product tree, which also includes OxC-beta for livestock and human applications. We believe these orders to be a positive step in building a recurring revenue stream.Taiwan Order. The 1,500 unit order is for the Company's Vivamune product, and represents the largest order from Avivagen's Taiwan-based distribution partner this year. It is also representative of the increased presence that the Company has undergone in the Asian markets, as more product is seeing higher consumer awareness, including OxC-beta as it is used in a premium dog food in Taiwan by a leading producer. Read More >>